Abstract
Bleomycin and ferric nitrilotriacetate (Fe-NTA) give rise to reactive oxygen species (ROS). Bleomycin was mutagenic in lacZ mouse kidney, liver and lung, but Fe-NTA was non-mutagenic in kidney and lung and marginally mutagenic in liver. Fe-NTA-treatment led to an increase in 8-hydroxydeoxyguanosine levels in kidney and liver, while the corresponding levels in bleomycin-treated mice were if anything, lower than those for bleomycin. It appears that factors other than simply the ability to generate ROS, play a role in mutagenesis by these compounds.
Original language | English (US) |
---|---|
Pages (from-to) | 41-46 |
Number of pages | 6 |
Journal | Cancer Letters |
Volume | 187 |
Issue number | 1-2 |
DOIs | |
State | Published - Dec 10 2002 |
Keywords
- Bleomycin
- Ferric nitrilotriacetate
- Mutagenesis
- Reactive oxygen species
- lacZ
ASJC Scopus subject areas
- Oncology
- Cancer Research